These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Bone and calcium update; bone research update. Osteoclastogenesis and osteoimmunology]. Nakashima T, Hayashi M, Takayanagi H. Clin Calcium; 2011 Dec; 21(12):93-102. PubMed ID: 22133829 [Abstract] [Full Text] [Related]
8. [RANKL as a target molecule for treatment of joint destruction]. Tanaka S. Clin Calcium; 2007 Apr; 17(4):586-92. PubMed ID: 17404489 [Abstract] [Full Text] [Related]
10. [Osteoimmunology: an integrated vision of immune and bone systems]. Gallois A, Mazzorana M, Vacher J, Jurdic P. Med Sci (Paris); 2009 Mar; 25(3):259-65. PubMed ID: 19361389 [Abstract] [Full Text] [Related]
11. The role of NFAT in osteoclast formation. Takayanagi H. Ann N Y Acad Sci; 2007 Nov; 1116():227-37. PubMed ID: 18083930 [Abstract] [Full Text] [Related]
13. [Involvement of osteoclasts in cartilage and bone destruction in rheumatoid arthritis]. Hikita A, Tanaka S. Nihon Rinsho; 2005 Jan; 63 Suppl 1():84-6. PubMed ID: 15799323 [No Abstract] [Full Text] [Related]
15. New regulation mechanisms of osteoclast differentiation. Nakashima T, Takayanagi H. Ann N Y Acad Sci; 2011 Dec; 1240():E13-8. PubMed ID: 22360322 [Abstract] [Full Text] [Related]
20. [Prevention of joint destruction by osteoclast-targeting therapy in search of new tools, such as OPG or cathepsin K inhibitor]. Kadono Y, Tanaka S. Clin Calcium; 2009 Mar; 19(3):387-93. PubMed ID: 19252249 [Abstract] [Full Text] [Related] Page: [Next] [New Search]